More sensitive HIT cell therapy shows promise against solid cancers
Medical Xpress
February 26, 2026
CAR T cell therapy has revolutionized the treatment of many blood cancers, but has shown little success against solid tumors, which account for over 85% of all cancers. Columbia researchers have now found that a new type of cell therapy—HIT cells, a cousin to CAR T with enhanced sensitivity—overcomes a major obstacle to treating solid tumors with cell therapy and can completely eliminate kidney, pancreatic, and ovarian cancers in mice. The research appears in the journal Science.
Verticals
healthmedical
Originally published on Medical Xpress on 2/26/2026